BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9449921)

  • 1. The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening.
    Grob JJ; Bonerandi JJ
    Arch Dermatol; 1998 Jan; 134(1):103-4. PubMed ID: 9449921
    [No Abstract]   [Full Text] [Related]  

  • 2. Ugly Duckling Sign as a Major Factor of Efficiency in Melanoma Detection.
    Gaudy-Marqueste C; Wazaefi Y; Bruneu Y; Triller R; Thomas L; Pellacani G; Malvehy J; Avril MF; Monestier S; Richard MA; Fertil B; Grob JJ
    JAMA Dermatol; 2017 Apr; 153(4):279-284. PubMed ID: 28196213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dermatologist's position concerning nevi: a vision ranging from "the ugly duckling" to "little red riding hood".
    Mascaro JM; Mascaro JM
    Arch Dermatol; 1998 Nov; 134(11):1484-5. PubMed ID: 9828892
    [No Abstract]   [Full Text] [Related]  

  • 4. First prospective study of the recognition process of melanoma in dermatological practice.
    Gachon J; Beaulieu P; Sei JF; Gouvernet J; Claudel JP; Lemaitre M; Richard MA; Grob JJ
    Arch Dermatol; 2005 Apr; 141(4):434-8. PubMed ID: 15837860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "ugly duckling" sign: agreement between observers.
    Scope A; Dusza SW; Halpern AC; Rabinovitz H; Braun RP; Zalaudek I; Argenziano G; Marghoob AA
    Arch Dermatol; 2008 Jan; 144(1):58-64. PubMed ID: 18209169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of a limited intra-individual diversity of nevi: intuitive perception of dominant clusters is a crucial step in the analysis of nevi by dermatologists.
    Wazaefi Y; Gaudy-Marqueste C; Avril MF; Malvehy J; Pellacani G; Thomas L; Triller R; Bruneu Y; Monestier S; Richard MA; Fertil B; Grob JJ
    J Invest Dermatol; 2013 Oct; 133(10):2355-2361. PubMed ID: 23594596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rare melanocytes and nevus-cell nevi].
    Frenk E; Mevorah B; Delacrétaz J
    Hautarzt; 1975 Dec; 26(12):619-24. PubMed ID: 1213881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant Melanoma in Association With a Thymic Nevus in a Patient With a Giant Congenital Nevus.
    Shvartser-Beryozkin Y; Yakobson A; Benharroch D; Saute M; Feinmesser M
    Am J Dermatopathol; 2017 Jul; 39(7):538-541. PubMed ID: 28033154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic globules in Spitz's nevi. New findings and a diagnostic sign.
    Kamino H; Flotte TJ; Misheloff E; Greco MA; Ackerman AB
    Am J Dermatopathol; 1979; 1(4):319-24. PubMed ID: 94511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is the presence of horny pseudocysts in the histological picture of nevus cell nevi a sign for a benign lesion?].
    Ingber A
    Z Hautkr; 1982 Oct; 57(19):1453-5. PubMed ID: 7148067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocytic nevi simulant of melanoma with medicolegal relevance.
    Massi G
    Virchows Arch; 2007 Sep; 451(3):623-47. PubMed ID: 17653760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing agents for the therapeutic prevention of melanoma: can the assessment of cutaneous precursor lesions help?
    Maguire WF; Kirkwood JM
    Future Oncol; 2020 Mar; 16(9):413-415. PubMed ID: 32100570
    [No Abstract]   [Full Text] [Related]  

  • 13. [Longitudinal melanonychia].
    Moulonguet I; Goettmann-Bonvallot S
    Ann Dermatol Venereol; 2016 Jan; 143(1):53-60; quiz 51-2. PubMed ID: 26795135
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dermatoscopic diagnosis of cutaneous malignant melanoma. Secondary prophylaxis].
    Lorentzen HF; Weismann K
    Ugeskr Laeger; 2000 Jun; 162(23):3312-6. PubMed ID: 10895596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nevi, other than dysplastic and Spitz nevi.
    Cochran AJ; Bailly C; Paul E; Dolbeau D
    Semin Diagn Pathol; 1993 Feb; 10(1):3-17. PubMed ID: 8506415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomic transitions and the histopathologic features of melanocytic nevi.
    Saida T; Kawachi S; Koga H
    Arch Dermatol; 2008 Sep; 144(9):1232-3; author reply 1233-4. PubMed ID: 18794479
    [No Abstract]   [Full Text] [Related]  

  • 17. Dysplastic nevi and malignant melanoma.
    Crutcher WA; Cohen PJ
    Am Fam Physician; 1990 Aug; 42(2):372-85. PubMed ID: 2200246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology and prevention of melanoma].
    Grob JJ; Richard MA
    Rev Prat; 2004 Jun; 54(11):1181-6. PubMed ID: 15496024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obtaining an Adequate Specimen for the Diagnosis of Pigmented Lesions.
    Snyder A; West SE; Miles CM; Feldman SR
    J Am Board Fam Med; 2015; 28(4):523-5. PubMed ID: 26152445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple interpretations of cancer risks from body mole counts in preventive care.
    Fusaro RM
    Arch Dermatol; 2001 Jun; 137(6):823. PubMed ID: 11405784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.